At Novo Nordisk Capital Markets Day, Co CFO Says Reasonable To Expect That We Should Be Able To Grow The Company By Mid-Single Digits Compound Annual Growth Rate Toward 2030

At Novo Nordisk's Capital Markets Day, the company's Co CFO stated that it is reasonable to expect a mid-single digits compound annual growth rate (CAGR) for the company towards 2030. This growth expectation indicates a positive outlook for the company's performance in the coming years.